Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Connecting molecular pathways to hereditary cancer risk syndromes.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting - 1 Jan 2013

Testa Joseph R, Malkin David, Schiffman Joshua D

Abstract excerpt

An understanding of the genetic causes and molecular pathways of hereditary cancer syndromes has historically informed our knowledge and treatment of all types of cancers. For this review, we focus on three rare syndromes and their associated genetic mutations including BAP1, TP53, and SDHx (SDHA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to SDHA gene
Share to Germ-Line Mutation
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplastic Syndromes, Hereditary

Share to Succinate Dehydrogenase

Share to Tumor Suppressor Protein p53

Share to Tumor Suppressor Proteins

Share to Ubiquitin Thiolesterase

Source

Open in PubMed Open full text

Identifiers

PMID: 23714463
DOI: 10.14694/EdBook_AM.2013.33.81
PMCID: PMC5889618

Genes

BAP1
SDHA
SDHAF2
SDHB
SDHC
SDHD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23714463-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Connecting molecular pathways to hereditary cancer risk syndromes.PMID 23714463Read ↗

Hereditary and Familial Tumor Syndromes: When to Think of Them? The Emerging Role of Pathologists as Sentinels of Genetic Cancer Predisposition.Semantic proximity Read ↗

Tumorigenesis Mechanisms Found in Hereditary Renal Cell Carcinoma: A ReviewSemantic proximity Read ↗

Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia.Semantic proximity Read ↗

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.Semantic proximity Read ↗

Biological Mechanisms and Clinical Significance of BAP1 Mutations in Human Cancer.Semantic proximity Read ↗

Advances in Molecular Mechanisms of Kidney Disease: Integrating Renal Tumorigenesis of Hereditary Cancer Syndrome.Semantic proximity Read ↗

Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.Semantic proximity Read ↗

Genetic predisposition to kidney cancer.Semantic proximity Read ↗

The Role of the Surgical Pathologist in the Recognition of Hereditary SDH-Deficient Tumor Syndromes.Semantic proximity Read ↗

From Familial Clustering to a Dedicated Classification: The Historical Recognition of Hereditary Tumor Syndromes in the WHO Classification of Tumors.Semantic proximity Read ↗

Tumours associated with BAP1 mutations.Semantic proximity Read ↗

The Importance of Multidisciplinary Approach in Early Detection of BAP1 Tumor Predisposition Syndrome: Clinical Management and Risk AssessmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.